Ross Hoffman
highactivehealthcare-execcentenepolicyumwarburg
Interactions
| Date | Type | Notes |
|---|---|---|
| ~Jan 30, 2026 | Call | Discussed UM policy angle. He's interested. (need more detail — backfill from memory) |
Notes
- Need to flesh out: what specifically did we discuss? What's his current role? What does he want to do with us?
- The Warburg overlap with Dan is worth exploring — is this the same contact at Warburg, or different paths in?
- Policy credibility + payer exec credibility is a powerful combination for fundraising narrative
Who
- Former CMO of Centene (one of the largest Medicaid managed care companies in the US)
- Interested in the policy angle around utilization management
- Connected to Warburg (Pincus?) — Dan Wilson also knows Warburg
Connection to Us
- Talked ~2 weeks ago (~late Jan / early Feb 2026)
- Engaged on the UM policy dimension — this is going to be relevant
- Shared Warburg connection with Dan Wilson
Why He Matters
- Former CMO of a major national payer — understands UM from the inside at massive scale
- Policy angle is increasingly important: CMS rules, state-level UM reform, prior auth regulation all shifting
- The policy + tech intersection is where DaisyAI's story gets stronger (we're not just automating — we're on the right side of regulatory direction)
- Warburg connection could be a fundraising or strategic path
- Centene background means deep Medicaid managed care expertise — different payer segment than Premera (commercial/BCBS)